Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The <scp>RHAPSODY</scp> Phase <scp>III</scp> Trial

RHAPSODY was the first well-powered clinical trial to show the positive risk-benefit ratio of 5-grass-pollen SLIT drops in adult participants with moderate-to-severe grass-pollen-induced ARC.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2025-12-24
DOI
https://doi.org/10.1111/all.70191
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The RHAPSODY Phase III Trial

Terrie Dalgaard, Ruta Gronskyte Juhl, Antoine Chartier, Philippe Devillier et al.
Allergy
Allergic Rhinitis and Sensitization
article

Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The RHAPSODY Phase III Trial

Terrie Dalgaard, Ruta Gronskyte Juhl, Antoine Chartier, Philippe Devillier, Alain Didier
article en

Abstract

RHAPSODY was the first well-powered clinical trial to show the positive risk-benefit ratio of 5-grass-pollen SLIT drops in adult participants with moderate-to-severe grass-pollen-induced ARC.

Allergy
Inserm (FR), ALK-Abelló (Denmark) (DK), Hôpital Larrey (FR), IQVIA (France) (FR), Hôpital Foch (FR)
GlaxoSmithKline, Sanofi
Openalex Percentile: Top 29%
Allergic Rhinitis and Sensitization
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.